|
|
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
100 Clinical Results associated with sGC x EP4 x EP2
100 Translational Medicine associated with sGC x EP4 x EP2
0 Patents (Medical) associated with sGC x EP4 x EP2